|
OMIM |
Link |
Information gain |
01 |
|
stature quantitative trait locus 3
|
[NCBI]
|
0.00333131
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.00333131
|
|
|
SRS
|
[NCBI]
|
0.00332714
|
|
|
GCY
|
[NCBI]
|
0.00299584
|
|
|
pygmy
|
[NCBI]
|
0.00273348
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.00260552
|
|
|
stature quantitative trait locus 8
|
[NCBI]
|
0.00249555
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.00249555
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.00249555
|
|
|
kbg syndrome
|
[NCBI]
|
0.00206767
|
|
|
spondyloepimetaphyseal dysplasia, sponastrime type
|
[NCBI]
|
0.00185667
|
|
|
acromicric dysplasia
|
[NCBI]
|
0.00166176
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.0014143
|
|
|
dubowitz syndrome
|
[NCBI]
|
0.00137944
|
|
|
spondylometaphyseal dysplasia, kozlowski type
|
[NCBI]
|
0.00129892
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00123351
|
|
|
costovertebral segmentation anomalies
|
[NCBI]
|
0.00113628
|
|
|
RA
|
[NCBI]
|
0.00106342
|
|
|
precocious puberty
|
[NCBI]
|
0.00094103
|
|
|
PWS
|
[NCBI]
|
0.000933137
|
|
|
DA4
|
[NCBI]
|
0.000829916
|
|
|
stature quantitative trait locus 7
|
[NCBI]
|
0.000829916
|
|
|
methionine malabsorption syndrome
|
[NCBI]
|
0.000829916
|
|
|
vertebral hypoplasia with lumbar kyphosis
|
[NCBI]
|
0.000829916
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.000829916
|
|
|
deafness, congenital, with vitiligo and achalasia
|
[NCBI]
|
0.000829916
|
|
|
ear, patella, short stature syndrome
|
[NCBI]
|
0.000815972
|
|
|
SLE
|
[NCBI]
|
0.000791186
|
|
|
ISS
|
[NCBI]
|
0.000734348
|
|
|
CF
|
[NCBI]
|
0.000630866
|
|
|
OD
|
[NCBI]
|
0.000621273
|
|
|
LWD
|
[NCBI]
|
0.00061806
|
|
|
ocular hypotelorism, submucosal cleft palate, and hypospadias
|
[NCBI]
|
0.000567203
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.000567203
|
|
|
SHOX
|
[NCBI]
|
0.000530467
|
|
|
NS1
|
[NCBI]
|
0.000496143
|
|
|
GH1
|
[NCBI]
|
0.000482054
|
|
|
hairy elbows
|
[NCBI]
|
0.000469601
|
|
|
adducted thumb-clubfoot syndrome
|
[NCBI]
|
0.000469601
|
|
|
megalencephaly
|
[NCBI]
|
0.000469601
|
|
|
kenny-caffey syndrome, type 2
|
[NCBI]
|
0.000469601
|
|
|
WTS
|
[NCBI]
|
0.000469601
|
|
|
MHAC
|
[NCBI]
|
0.000469601
|
|
|
porokeratosis of mibelli
|
[NCBI]
|
0.000407097
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000407097
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.000407097
|
|
|
pituitary dwarfism i
|
[NCBI]
|
0.000382572
|
|
|
gapo syndrome
|
[NCBI]
|
0.000361262
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000361262
|
|
|
kyphomelic dysplasia
|
[NCBI]
|
0.000325244
|
|
|
spondyloepimetaphyseal dysplasia with multiple dislocations
|
[NCBI]
|
0.000325244
|
|
|
GHR
|
[NCBI]
|
0.000314321
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
0.000311506
|
|
|
short syndrome
|
[NCBI]
|
0.000296308
|
|
|
BMND3
|
[NCBI]
|
0.000295714
|
|
|
DA5
|
[NCBI]
|
0.000295714
|
|
|
DBQD
|
[NCBI]
|
0.000295714
|
|
|
acrodysostosis
|
[NCBI]
|
0.000295714
|
|
|
gordon syndrome
|
[NCBI]
|
0.000270795
|
|
|
IGES
|
[NCBI]
|
0.000249323
|
|
|
mohr syndrome
|
[NCBI]
|
0.000249323
|
|
|
hunter-mcalpine craniosynostosis syndrome
|
[NCBI]
|
0.000237944
|
|
|
growth-mental deficiency syndrome of myhre
|
[NCBI]
|
0.000237944
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000230528
|
|
|
CD
|
[NCBI]
|
0.000215692
|
|
|
acroosteolysis with osteoporosis and changes in skull and mandible
|
[NCBI]
|
0.000213871
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
0.000213749
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
0.000211162
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
0.000209839
|
|
|
alopecia-contractures-dwarfism mental retardation syndrome
|
[NCBI]
|
0.000203364
|
|
|
devriendt syndrome
|
[NCBI]
|
0.000203364
|
|
|
ACH
|
[NCBI]
|
0.000202147
|
|
|
microcephaly, autosomal dominant
|
[NCBI]
|
0.000198961
|
|
|
marden-walker syndrome
|
[NCBI]
|
0.000198961
|
|
|
AD
|
[NCBI]
|
0.000197482
|
|
|
MAS
|
[NCBI]
|
0.000185922
|
|
|
IGFALS
|
[NCBI]
|
0.000171552
|
|
|
CHH
|
[NCBI]
|
0.000167614
|
|
|
pituitary dwarfism due to isolated growth hormone deficiency, autosomal dominant
|
[NCBI]
|
0.000165666
|
|
|
HCH
|
[NCBI]
|
0.000163918
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.000162113
|
|
|
VDR
|
[NCBI]
|
0.000156915
|
|
|
martsolf syndrome
|
[NCBI]
|
0.000148066
|
|
|
branchial arch syndrome, x-linked
|
[NCBI]
|
0.000148066
|
|
|
marshall-smith syndrome
|
[NCBI]
|
0.000148066
|
|
|
insulin-like growth factor i deficiency
|
[NCBI]
|
0.000136322
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
0.000136322
|
|
|
TRPS3
|
[NCBI]
|
0.000136322
|
|
|
TRPS1
|
[NCBI]
|
0.000134816
|
|
|
faciogenital dysplasia
|
[NCBI]
|
0.000131929
|
|
|
MRXHF1
|
[NCBI]
|
0.000124083
|
|
|
floating-harbor syndrome
|
[NCBI]
|
0.000120087
|
|
|
three m syndrome
|
[NCBI]
|
0.000120087
|
|
|
JBTS1
|
[NCBI]
|
0.000117958
|
|
|
PTH
|
[NCBI]
|
0.000114041
|
|
|
MVP
|
[NCBI]
|
0.000104294
|
|
|
IS1
|
[NCBI]
|
0.000103143
|
|
|
AHO
|
[NCBI]
|
0.000102903
|
|
|
thumb deformity and alopecia
|
[NCBI]
|
0.00010166
|
|
|
gonadal dysgenesis, xy type, with associated anomalies
|
[NCBI]
|
0.00010166
|
|
|
spondylometaphyseal dysplasia, algerian type
|
[NCBI]
|
0.00010166
|
|
|
patent ductus arteriosus and bicuspid aortic valve with hand anomalies
|
[NCBI]
|
0.00010166
|
|
|
phenformin 4-hydroxylation
|
[NCBI]
|
0.00010166
|
|
|
mastocytosis, cutaneous, with short stature, conductive hearing loss and microtia
|
[NCBI]
|
0.00010166
|
|
|
disproportionate short stature with ptosis and valvular heart lesions
|
[NCBI]
|
0.00010166
|
|
|
cleidorhizomelic syndrome
|
[NCBI]
|
0.00010166
|
|
|
microcephaly with cervical spine fusion anomalies
|
[NCBI]
|
0.00010166
|
|
|
hand and foot deformity with flat facies
|
[NCBI]
|
0.00010166
|
|
|
corneodermatoosseous syndrome
|
[NCBI]
|
0.00010166
|
|
|
pituitary dwarfism with small sella turcica
|
[NCBI]
|
0.00010166
|
|
|
metaphyseal anadysplasia
|
[NCBI]
|
0.00010166
|
|
|
arthrogryposis, distal, type 2e
|
[NCBI]
|
0.00010166
|
|
|
rhizomelic dysplasia, patterson-lowry type
|
[NCBI]
|
0.00010166
|
|
|
arthrogryposis, distal, with peculiar facies and hydronephrosis
|
[NCBI]
|
0.00010166
|
|
|
edema, familial idiopathic, prepubertal
|
[NCBI]
|
0.00010166
|
|
|
laryngotracheal stenosis, progressive, with short stature and arthropathy
|
[NCBI]
|
0.00010166
|
|
|
brachydactyly-distal symphalangism syndrome
|
[NCBI]
|
0.00010166
|
|
|
asthma, short stature, and elevated iga
|
[NCBI]
|
0.00010166
|
|
|
short stature syndrome, brussels type
|
[NCBI]
|
0.00010166
|
|
|
ulnar/fibular ray defect and brachydactyly
|
[NCBI]
|
0.00010166
|
|
|
KPC
|
[NCBI]
|
0.00010166
|
|
|
marfanoid mental retardation syndrome, autosomal
|
[NCBI]
|
0.00010166
|
|
|
BDA1
|
[NCBI]
|
0.0001
|
|
|
SEDT
|
[NCBI]
|
9.62949e-05
|
|
|
GHRH
|
[NCBI]
|
9.47278e-05
|
|
|
multiple pterygium syndrome, escobar variant
|
[NCBI]
|
9.29249e-05
|
|
|
sotos syndrome
|
[NCBI]
|
8.95462e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
8.49479e-05
|
|
|
PFIC1
|
[NCBI]
|
8.4343e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
7.74044e-05
|
|
|
IGF1
|
[NCBI]
|
7.45007e-05
|
|
|
aarskog syndrome
|
[NCBI]
|
7.40114e-05
|
|
|
cleft lip/palate with abnormal thumbs and microcephaly
|
[NCBI]
|
7.40114e-05
|
|
|
acrofrontofacionasal dysostosis, severe
|
[NCBI]
|
7.40114e-05
|
|
|
STQTL9
|
[NCBI]
|
7.40114e-05
|
|
|
bowing of legs, anterior, with dwarfism
|
[NCBI]
|
7.40114e-05
|
|
|
radial-renal syndrome
|
[NCBI]
|
7.40114e-05
|
|
|
sjogren-larsson-like ichthyosis without cns or eye involvement
|
[NCBI]
|
7.40114e-05
|
|
|
body length, mouse, human homolog
|
[NCBI]
|
7.40114e-05
|
|
|
nicolaides-baraitser syndrome
|
[NCBI]
|
7.40114e-05
|
|
|
creases, infra-auricular cutaneous, with tall stature and advanced bone age
|
[NCBI]
|
7.40114e-05
|
|
|
TCC
|
[NCBI]
|
7.40114e-05
|
|
|
prader-willi habitus, osteopenia, and camptodactyly
|
[NCBI]
|
7.40114e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
7.34294e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
6.98582e-05
|
|
|
PSACH
|
[NCBI]
|
6.53758e-05
|
|
|
ALMS
|
[NCBI]
|
6.5109e-05
|
|
|
RCDP1
|
[NCBI]
|
6.3662e-05
|
|
|
craniofacial dysostosis with diaphyseal hyperplasia
|
[NCBI]
|
6.36539e-05
|
|
|
camera-marugo-cohen syndrome
|
[NCBI]
|
6.36539e-05
|
|
|
NS4
|
[NCBI]
|
6.36539e-05
|
|
|
macrocephaly
|
[NCBI]
|
6.36539e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
6.31746e-05
|
|
|
TTDN1
|
[NCBI]
|
6.11373e-05
|
|
|
PTHR1
|
[NCBI]
|
5.95262e-05
|
|
|
OPTB2
|
[NCBI]
|
5.69718e-05
|
|
|
ruvalcaba syndrome
|
[NCBI]
|
5.69718e-05
|
|
|
varicose veins
|
[NCBI]
|
5.69718e-05
|
|
|
precocious puberty, male-limited
|
[NCBI]
|
5.69718e-05
|
|
|
nevo syndrome
|
[NCBI]
|
5.69718e-05
|
|
|
ectopia lentis
|
[NCBI]
|
5.69718e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
5.28655e-05
|
|
|
enterokinase deficiency
|
[NCBI]
|
5.20352e-05
|
|
|
ODG1
|
[NCBI]
|
5.20352e-05
|
|
|
iris coloboma with ptosis, hypertelorism, and mental retardation
|
[NCBI]
|
5.20352e-05
|
|
|
TTDN1
|
[NCBI]
|
5.20352e-05
|
|
|
GCS1
|
[NCBI]
|
5.20352e-05
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
5.20352e-05
|
|
|
COH1
|
[NCBI]
|
5.18715e-05
|
|
|
CDLS1
|
[NCBI]
|
5.08523e-05
|
|
|
BTHS
|
[NCBI]
|
4.99553e-05
|
|
|
thyrotropin deficiency, isolated
|
[NCBI]
|
4.81267e-05
|
|
|
buschke-ollendorff syndrome
|
[NCBI]
|
4.81267e-05
|
|
|
BDE
|
[NCBI]
|
4.81267e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
4.81267e-05
|
|
|
serpentine fibula-polycystic kidney syndrome
|
[NCBI]
|
4.81267e-05
|
|
|
PPNAD1
|
[NCBI]
|
4.81267e-05
|
|
|
TRAPPC2
|
[NCBI]
|
4.70565e-05
|
|
|
IGFBP3
|
[NCBI]
|
4.53638e-05
|
|
|
AEXS
|
[NCBI]
|
4.48976e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
4.33015e-05
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
4.21513e-05
|
|
|
TRS
|
[NCBI]
|
4.21513e-05
|
|
|
PHA2
|
[NCBI]
|
4.21513e-05
|
|
|
ODG2
|
[NCBI]
|
4.21513e-05
|
|
|
AMDM
|
[NCBI]
|
4.21513e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
4.18467e-05
|
|
|
C7ORF10
|
[NCBI]
|
4.05578e-05
|
|
|
NF1
|
[NCBI]
|
4.01365e-05
|
|
|
EDM4
|
[NCBI]
|
3.9766e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
3.9766e-05
|
|
|
DA1
|
[NCBI]
|
3.76609e-05
|
|
|
WZS
|
[NCBI]
|
3.76609e-05
|
|
|
PBT
|
[NCBI]
|
3.76609e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
3.76609e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
3.76609e-05
|
|
|
SMMCI
|
[NCBI]
|
3.76609e-05
|
|
|
GNRH1
|
[NCBI]
|
3.69408e-05
|
|
|
IGF1R
|
[NCBI]
|
3.64515e-05
|
|
|
HOS
|
[NCBI]
|
3.60886e-05
|
|
|
BDB1
|
[NCBI]
|
3.57797e-05
|
|
|
BDC
|
[NCBI]
|
3.57797e-05
|
|
|
WSS
|
[NCBI]
|
3.57797e-05
|
|
|
OSMED
|
[NCBI]
|
3.57797e-05
|
|
|
IFD
|
[NCBI]
|
3.57797e-05
|
|
|
STAT5B
|
[NCBI]
|
3.50756e-05
|
|
|
GHRL
|
[NCBI]
|
3.50756e-05
|
|
|
DA2B
|
[NCBI]
|
3.40815e-05
|
|
|
HHS
|
[NCBI]
|
3.40815e-05
|
|
|
osteoporosis, juvenile
|
[NCBI]
|
3.40815e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
3.40815e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
3.40815e-05
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
3.40815e-05
|
|
|
TD1
|
[NCBI]
|
3.38724e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
3.25356e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
3.25356e-05
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
3.25356e-05
|
|
|
SHOXY
|
[NCBI]
|
3.23167e-05
|
|
|
ATRX
|
[NCBI]
|
3.19737e-05
|
|
|
RP
|
[NCBI]
|
3.1187e-05
|
|
|
GCCD1
|
[NCBI]
|
3.11185e-05
|
|
|
NFNS
|
[NCBI]
|
3.11185e-05
|
|
|
UMS
|
[NCBI]
|
2.98119e-05
|
|
|
propionic acidemia
|
[NCBI]
|
2.98119e-05
|
|
|
MCPH1
|
[NCBI]
|
2.98119e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
2.98119e-05
|
|
|
SOST
|
[NCBI]
|
2.98119e-05
|
|
|
AIS
|
[NCBI]
|
2.88844e-05
|
|
|
PPAC
|
[NCBI]
|
2.86009e-05
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
2.86009e-05
|
|
|
CSID
|
[NCBI]
|
2.86009e-05
|
|
|
hartnup disorder
|
[NCBI]
|
2.86009e-05
|
|
|
phenylketonuria
|
[NCBI]
|
2.80239e-05
|
|
|
OPTB3
|
[NCBI]
|
2.74735e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
2.74735e-05
|
|
|
MC4R
|
[NCBI]
|
2.69025e-05
|
|
|
BGS
|
[NCBI]
|
2.642e-05
|
|
|
FBS
|
[NCBI]
|
2.642e-05
|
|
|
leopard syndrome 1
|
[NCBI]
|
2.642e-05
|
|
|
weaver syndrome
|
[NCBI]
|
2.642e-05
|
|
|
FGFR3
|
[NCBI]
|
2.57064e-05
|
|
|
PRSS7
|
[NCBI]
|
2.56983e-05
|
|
|
PLXNA2
|
[NCBI]
|
2.56983e-05
|
|
|
SHOX2
|
[NCBI]
|
2.56983e-05
|
|
|
frank-ter haar syndrome
|
[NCBI]
|
2.56983e-05
|
|
|
NPR2
|
[NCBI]
|
2.56983e-05
|
|
|
ESX1L
|
[NCBI]
|
2.56983e-05
|
|
|
BFLS
|
[NCBI]
|
2.5432e-05
|
|
|
MYH8
|
[NCBI]
|
2.45069e-05
|
|
|
DA2A
|
[NCBI]
|
2.45027e-05
|
|
|
masa syndrome
|
[NCBI]
|
2.45027e-05
|
|
|
CDPX1
|
[NCBI]
|
2.36261e-05
|
|
|
histidinemia
|
[NCBI]
|
2.36261e-05
|
|
|
SRY
|
[NCBI]
|
2.28919e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
2.27974e-05
|
|
|
SRD5A1
|
[NCBI]
|
2.26709e-05
|
|
|
CHNG2
|
[NCBI]
|
2.2012e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
2.2012e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
2.2012e-05
|
|
|
FBN1
|
[NCBI]
|
2.18643e-05
|
|
|
COL1A1
|
[NCBI]
|
2.14799e-05
|
|
|
TRPS1
|
[NCBI]
|
2.12758e-05
|
|
|
ATP8B1
|
[NCBI]
|
2.12758e-05
|
|
|
SHC1
|
[NCBI]
|
2.12758e-05
|
|
|
SOS1
|
[NCBI]
|
2.12758e-05
|
|
|
SCDO1
|
[NCBI]
|
2.12663e-05
|
|
|
osteoporosis
|
[NCBI]
|
2.12663e-05
|
|
|
FGD1
|
[NCBI]
|
2.06864e-05
|
|
|
NPPB
|
[NCBI]
|
2.06864e-05
|
|
|
OCRL
|
[NCBI]
|
2.05569e-05
|
|
|
AHC
|
[NCBI]
|
2.05569e-05
|
|
|
TBX3
|
[NCBI]
|
2.01513e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
1.9881e-05
|
|
|
OKS
|
[NCBI]
|
1.92358e-05
|
|
|
BGLAP
|
[NCBI]
|
1.89053e-05
|
|
|
PRL
|
[NCBI]
|
1.83584e-05
|
|
|
LEP
|
[NCBI]
|
1.81291e-05
|
|
|
COL5A1
|
[NCBI]
|
1.8035e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.74639e-05
|
|
|
PAPPA
|
[NCBI]
|
1.73672e-05
|
|
|
GAD2
|
[NCBI]
|
1.67693e-05
|
|
|
TBX5
|
[NCBI]
|
1.64924e-05
|
|
|
SGBS1
|
[NCBI]
|
1.64009e-05
|
|
|
PLOD1
|
[NCBI]
|
1.62284e-05
|
|
|
GHSR
|
[NCBI]
|
1.62284e-05
|
|
|
EBP
|
[NCBI]
|
1.62284e-05
|
|
|
LHB
|
[NCBI]
|
1.57347e-05
|
|
|
CYP11B1
|
[NCBI]
|
1.57347e-05
|
|
|
CTSK
|
[NCBI]
|
1.50669e-05
|
|
|
SJS1
|
[NCBI]
|
1.49551e-05
|
|
|
CDPX2
|
[NCBI]
|
1.49551e-05
|
|
|
TNF
|
[NCBI]
|
1.48941e-05
|
|
|
PROP1
|
[NCBI]
|
1.48609e-05
|
|
|
HMGA2
|
[NCBI]
|
1.46622e-05
|
|
|
FABP2
|
[NCBI]
|
1.46622e-05
|
|
|
SMA3
|
[NCBI]
|
1.45083e-05
|
|
|
FIH
|
[NCBI]
|
1.45083e-05
|
|
|
CYP11B2
|
[NCBI]
|
1.42849e-05
|
|
|
KCNJ11
|
[NCBI]
|
1.42849e-05
|
|
|
PTPN11
|
[NCBI]
|
1.41055e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.40773e-05
|
|
|
ACP1
|
[NCBI]
|
1.32866e-05
|
|
|
NR0B1
|
[NCBI]
|
1.28482e-05
|
|
|
IGER
|
[NCBI]
|
1.24964e-05
|
|
|
RSTS
|
[NCBI]
|
1.24964e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.24426e-05
|
|
|
KAL1
|
[NCBI]
|
1.20653e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
1.19452e-05
|
|
|
ABL
|
[NCBI]
|
1.14417e-05
|
|
|
SCS
|
[NCBI]
|
1.1112e-05
|
|
|
INSL3
|
[NCBI]
|
1.09715e-05
|
|
|
SLC2A2
|
[NCBI]
|
1.06832e-05
|
|
|
INS
|
[NCBI]
|
1.04716e-05
|
|
|
CYP19A1
|
[NCBI]
|
1.02356e-05
|
|
|
galactosemia
|
[NCBI]
|
1.01819e-05
|
|
|
LNS
|
[NCBI]
|
1.01819e-05
|
|
|
GPT
|
[NCBI]
|
9.9037e-06
|
|
|
obesity
|
[NCBI]
|
9.89018e-06
|
|
|
TF
|
[NCBI]
|
9.5562e-06
|
|
|
FSHR
|
[NCBI]
|
9.44319e-06
|
|
|
CLS
|
[NCBI]
|
9.33192e-06
|
|
|
BMP2
|
[NCBI]
|
9.08926e-06
|
|
|
ARPKD
|
[NCBI]
|
9.06474e-06
|
|
|
MTTL1
|
[NCBI]
|
9.0214e-06
|
|
|
HRG
|
[NCBI]
|
8.8884e-06
|
|
|
LCT
|
[NCBI]
|
8.50977e-06
|
|
|
LEPR
|
[NCBI]
|
7.88434e-06
|
|
|
SHBG
|
[NCBI]
|
7.56833e-06
|
|
|
ATM
|
[NCBI]
|
6.79682e-06
|
|
|
HGPS
|
[NCBI]
|
6.76631e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
6.76631e-06
|
|
|
CCK
|
[NCBI]
|
6.59771e-06
|
|
|
LPI
|
[NCBI]
|
6.37654e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
6.37654e-06
|
|
|
CEACAM5
|
[NCBI]
|
6.00096e-06
|
|
|
DMD
|
[NCBI]
|
5.95056e-06
|
|
|
BDNF
|
[NCBI]
|
5.91096e-06
|
|
|
NPY
|
[NCBI]
|
5.90974e-06
|
|
|
CRH
|
[NCBI]
|
5.75866e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
5.65547e-06
|
|
|
FA
|
[NCBI]
|
5.54408e-06
|
|
|
VIP
|
[NCBI]
|
5.53634e-06
|
|
|
CASR
|
[NCBI]
|
5.37607e-06
|
|
|
IBD1
|
[NCBI]
|
5.32189e-06
|
|
|
ABP1
|
[NCBI]
|
5.19942e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
5.16139e-06
|
|
|
SDS
|
[NCBI]
|
5.00492e-06
|
|
|
breast cancer
|
[NCBI]
|
4.85237e-06
|
|
|
IHH
|
[NCBI]
|
4.63735e-06
|
|
|
OXT
|
[NCBI]
|
4.53911e-06
|
|
|
CPI
|
[NCBI]
|
4.45511e-06
|
|
|
COMP
|
[NCBI]
|
4.10556e-06
|
|
|
CGD
|
[NCBI]
|
4.0137e-06
|
|
|
MPO
|
[NCBI]
|
3.84922e-06
|
|
|
HGF
|
[NCBI]
|
3.62791e-06
|
|
|
AFP
|
[NCBI]
|
3.42578e-06
|
|
|
FMF
|
[NCBI]
|
3.09892e-06
|
|
|
AVP
|
[NCBI]
|
3.03547e-06
|
|
|
AMH
|
[NCBI]
|
2.95602e-06
|
|
|
APS1
|
[NCBI]
|
2.86883e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.69771e-06
|
|
|
APOB
|
[NCBI]
|
2.36324e-06
|
|
|
CAT
|
[NCBI]
|
2.15811e-06
|
|
|
TPO
|
[NCBI]
|
1.91494e-06
|
|
|
SCZD
|
[NCBI]
|
1.8304e-06
|
|
|
TG
|
[NCBI]
|
1.47743e-06
|
|
|
RTT
|
[NCBI]
|
1.42258e-06
|
|
|
MFS
|
[NCBI]
|
1.26429e-06
|
|
|
KLK3
|
[NCBI]
|
9.33191e-07
|
|
|
BBS
|
[NCBI]
|
8.83115e-07
|
|
|
AR
|
[NCBI]
|
8.20197e-07
|
|
|
CYP1A1
|
[NCBI]
|
7.77516e-07
|
|
|
ALB
|
[NCBI]
|
6.70695e-07
|
|
|
SOD2
|
[NCBI]
|
5.13428e-07
|
|
|
ACP5
|
[NCBI]
|
4.60236e-07
|
|
|
BWS
|
[NCBI]
|
4.51373e-07
|
|
|
HD
|
[NCBI]
|
3.36209e-07
|
|
|
COMT
|
[NCBI]
|
2.28944e-07
|
|
|
PTHLH
|
[NCBI]
|
1.87335e-07
|
|
|
EPO
|
[NCBI]
|
1.32194e-07
|
|
|
CNTF
|
[NCBI]
|
1.02565e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
5.44983e-08
|
|
|
LPL
|
[NCBI]
|
5.12808e-08
|
|
|
HBB
|
[NCBI]
|
7.74828e-09
|
|
|
PPARA
|
[NCBI]
|
7.16725e-09
|
|
|
WBS
|
[NCBI]
|
4.3409e-09
|
|
|
AS
|
[NCBI]
|
1.40281e-09
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
4.37761e-11
|
|